

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 5.75444221 |
| 2 | piRNA metabolic process (GO:0034587) | 4.78465765 |
| 3 | protein polyglutamylation (GO:0018095) | 4.76782153 |
| 4 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.75269372 |
| 5 | behavioral response to nicotine (GO:0035095) | 4.52674770 |
| 6 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.42941575 |
| 7 | DNA deamination (GO:0045006) | 4.32160607 |
| 8 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.31847059 |
| 9 | regulation of action potential (GO:0098900) | 4.04438420 |
| 10 | behavioral response to ethanol (GO:0048149) | 3.76116699 |
| 11 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.73218748 |
| 12 | regulation of sarcomere organization (GO:0060297) | 3.71872622 |
| 13 | L-fucose catabolic process (GO:0042355) | 3.71336515 |
| 14 | fucose catabolic process (GO:0019317) | 3.71336515 |
| 15 | L-fucose metabolic process (GO:0042354) | 3.71336515 |
| 16 | ribonucleoprotein complex disassembly (GO:0032988) | 3.71319079 |
| 17 | protein neddylation (GO:0045116) | 3.68072061 |
| 18 | positive regulation of interleukin-17 production (GO:0032740) | 3.65685571 |
| 19 | adult feeding behavior (GO:0008343) | 3.53974657 |
| 20 | cellular ketone body metabolic process (GO:0046950) | 3.52988601 |
| 21 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.52843887 |
| 22 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.43222781 |
| 23 | cytidine metabolic process (GO:0046087) | 3.37127252 |
| 24 | cytidine catabolic process (GO:0006216) | 3.37127252 |
| 25 | cytidine deamination (GO:0009972) | 3.37127252 |
| 26 | cellular response to interleukin-15 (GO:0071350) | 3.33894563 |
| 27 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.29036842 |
| 28 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.28562021 |
| 29 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.28562021 |
| 30 | ketone body metabolic process (GO:1902224) | 3.27018656 |
| 31 | organelle disassembly (GO:1903008) | 3.26172386 |
| 32 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.11403451 |
| 33 | regulation of protein glycosylation (GO:0060049) | 3.09266870 |
| 34 | negative regulation of protein localization to cell surface (GO:2000009) | 3.07734342 |
| 35 | regulation of hexokinase activity (GO:1903299) | 3.07084912 |
| 36 | regulation of glucokinase activity (GO:0033131) | 3.07084912 |
| 37 | inner mitochondrial membrane organization (GO:0007007) | 3.04976889 |
| 38 | dopamine transport (GO:0015872) | 3.04146651 |
| 39 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.03692966 |
| 40 | positive regulation of cell killing (GO:0031343) | 3.03334714 |
| 41 | regulation of acrosome reaction (GO:0060046) | 2.99291584 |
| 42 | viral mRNA export from host cell nucleus (GO:0046784) | 2.98931109 |
| 43 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.97862688 |
| 44 | nucleobase catabolic process (GO:0046113) | 2.97022140 |
| 45 | kidney morphogenesis (GO:0060993) | 2.96896359 |
| 46 | axoneme assembly (GO:0035082) | 2.96164306 |
| 47 | sphingosine metabolic process (GO:0006670) | 2.96032835 |
| 48 | acrosome assembly (GO:0001675) | 2.95632105 |
| 49 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.95266020 |
| 50 | retinal cone cell development (GO:0046549) | 2.92585024 |
| 51 | sphingoid metabolic process (GO:0046519) | 2.85028465 |
| 52 | diol metabolic process (GO:0034311) | 2.81227930 |
| 53 | regulation of natural killer cell differentiation (GO:0032823) | 2.77598448 |
| 54 | lymph node development (GO:0048535) | 2.74958960 |
| 55 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.74265774 |
| 56 | regulation of skeletal muscle contraction (GO:0014819) | 2.73314144 |
| 57 | positive regulation of fatty acid transport (GO:2000193) | 2.73226664 |
| 58 | response to interleukin-15 (GO:0070672) | 2.73103061 |
| 59 | somite rostral/caudal axis specification (GO:0032525) | 2.71985264 |
| 60 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.71604251 |
| 61 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.70560365 |
| 62 | neuronal action potential (GO:0019228) | 2.67847794 |
| 63 | regulation of cell killing (GO:0031341) | 2.66674859 |
| 64 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.65466560 |
| 65 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.65466560 |
| 66 | phosphorelay signal transduction system (GO:0000160) | 2.57358234 |
| 67 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.57289519 |
| 68 | positive regulation of meiosis (GO:0045836) | 2.55758347 |
| 69 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.55539712 |
| 70 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.54984120 |
| 71 | opioid receptor signaling pathway (GO:0038003) | 2.54146969 |
| 72 | postreplication repair (GO:0006301) | 2.53343452 |
| 73 | activated T cell proliferation (GO:0050798) | 2.51098852 |
| 74 | regulation of memory T cell differentiation (GO:0043380) | 2.48398347 |
| 75 | transmission of nerve impulse (GO:0019226) | 2.48306101 |
| 76 | regulation of T cell chemotaxis (GO:0010819) | 2.48290161 |
| 77 | positive regulation of T cell chemotaxis (GO:0010820) | 2.48290161 |
| 78 | primary amino compound metabolic process (GO:1901160) | 2.46454555 |
| 79 | thyroid hormone metabolic process (GO:0042403) | 2.45681111 |
| 80 | protein-cofactor linkage (GO:0018065) | 2.45496671 |
| 81 | replication fork processing (GO:0031297) | 2.45328281 |
| 82 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.44382474 |
| 83 | oxidative demethylation (GO:0070989) | 2.43826541 |
| 84 | regulation of membrane repolarization (GO:0060306) | 2.42392204 |
| 85 | positive regulation of icosanoid secretion (GO:0032305) | 2.42323786 |
| 86 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.40592021 |
| 87 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.39783012 |
| 88 | termination of RNA polymerase III transcription (GO:0006386) | 2.39686672 |
| 89 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.39686672 |
| 90 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.39390826 |
| 91 | nucleotide transmembrane transport (GO:1901679) | 2.38212527 |
| 92 | DNA methylation involved in gamete generation (GO:0043046) | 2.38056047 |
| 93 | negative regulation of adaptive immune response (GO:0002820) | 2.37878800 |
| 94 | regulation of female receptivity (GO:0045924) | 2.37576894 |
| 95 | regulation of neurotransmitter uptake (GO:0051580) | 2.37144715 |
| 96 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.36846948 |
| 97 | positive regulation of meiotic cell cycle (GO:0051446) | 2.35608736 |
| 98 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.34370345 |
| 99 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.33409880 |
| 100 | regulation of chronic inflammatory response (GO:0002676) | 2.32044117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_22108803_ChIP-Seq_LS180_Human | 3.92984376 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.33925308 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.23851236 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.21060607 |
| 5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.90912849 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.88466618 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.62072314 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.42335071 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.31154616 |
| 10 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.19581622 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.18575896 |
| 12 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.12887780 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.07857665 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.05161767 |
| 15 | P300_19829295_ChIP-Seq_ESCs_Human | 1.91346262 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.89611053 |
| 17 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.87834286 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.87605666 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.87575897 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.83830716 |
| 21 | FUS_26573619_Chip-Seq_HEK293_Human | 1.80956738 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.78695214 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.76677040 |
| 24 | EWS_26573619_Chip-Seq_HEK293_Human | 1.75490499 |
| 25 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.72269488 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.61175136 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.58780741 |
| 28 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.57079051 |
| 29 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.54716625 |
| 30 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.54716625 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54601130 |
| 32 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.52569422 |
| 33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.52300872 |
| 34 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50829024 |
| 35 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.50777909 |
| 36 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.49822963 |
| 37 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.48537076 |
| 38 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47999459 |
| 39 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.47947395 |
| 40 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.45601082 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44860646 |
| 42 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.41418147 |
| 43 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.39771321 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39130378 |
| 45 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37908050 |
| 46 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.37397570 |
| 47 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.37397570 |
| 48 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.37278433 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37210422 |
| 50 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.36298361 |
| 51 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.36089005 |
| 52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34984250 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33955708 |
| 54 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.33736865 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31858042 |
| 56 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.30830510 |
| 57 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.29486062 |
| 58 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29186760 |
| 59 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27729622 |
| 60 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.26345917 |
| 61 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26017248 |
| 62 | TCF4_23295773_ChIP-Seq_U87_Human | 1.25551738 |
| 63 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.25306087 |
| 64 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.24852664 |
| 65 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.24852664 |
| 66 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.23392302 |
| 67 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21040154 |
| 68 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.19593289 |
| 69 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.19593289 |
| 70 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.18844390 |
| 71 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.18755166 |
| 72 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.17895525 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17791511 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17675945 |
| 75 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.17646553 |
| 76 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16768417 |
| 77 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.16649983 |
| 78 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14950763 |
| 79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.14280354 |
| 80 | NCOR_22424771_ChIP-Seq_293T_Human | 1.11768028 |
| 81 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.08677223 |
| 82 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08443051 |
| 83 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08231013 |
| 84 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07865659 |
| 85 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04478117 |
| 86 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02519272 |
| 87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02388918 |
| 88 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00047712 |
| 89 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99847398 |
| 90 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.98759598 |
| 91 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98241111 |
| 92 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.97220104 |
| 93 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.96615780 |
| 94 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96432703 |
| 95 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.96269463 |
| 96 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.95493569 |
| 97 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.93869304 |
| 98 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.93654704 |
| 99 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93370198 |
| 100 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.92998251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.46397191 |
| 2 | MP0001968_abnormal_touch/_nociception | 3.09046986 |
| 3 | MP0005646_abnormal_pituitary_gland | 3.04896956 |
| 4 | MP0003646_muscle_fatigue | 2.89640288 |
| 5 | MP0003950_abnormal_plasma_membrane | 2.89520035 |
| 6 | MP0005075_abnormal_melanosome_morpholog | 2.78974494 |
| 7 | MP0002102_abnormal_ear_morphology | 2.62667158 |
| 8 | MP0008872_abnormal_physiological_respon | 2.59791703 |
| 9 | MP0000569_abnormal_digit_pigmentation | 2.50951955 |
| 10 | MP0005645_abnormal_hypothalamus_physiol | 2.37283430 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.34303763 |
| 12 | MP0004142_abnormal_muscle_tone | 2.27439601 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.23782556 |
| 14 | MP0004742_abnormal_vestibular_system | 2.22692788 |
| 15 | MP0009745_abnormal_behavioral_response | 2.12790783 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.12240901 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 2.03859095 |
| 18 | MP0006292_abnormal_olfactory_placode | 2.00431759 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.00264729 |
| 20 | MP0000749_muscle_degeneration | 1.98664968 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.98480272 |
| 22 | MP0009046_muscle_twitch | 1.95428824 |
| 23 | MP0004270_analgesia | 1.94336729 |
| 24 | MP0002163_abnormal_gland_morphology | 1.89983577 |
| 25 | MP0003880_abnormal_central_pattern | 1.87752848 |
| 26 | MP0003787_abnormal_imprinting | 1.86999212 |
| 27 | MP0003045_fibrosis | 1.84654213 |
| 28 | MP0005551_abnormal_eye_electrophysiolog | 1.82497201 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.78446414 |
| 30 | MP0002272_abnormal_nervous_system | 1.75789384 |
| 31 | MP0005360_urolithiasis | 1.72923619 |
| 32 | MP0003136_yellow_coat_color | 1.72705346 |
| 33 | MP0003195_calcinosis | 1.71018380 |
| 34 | MP0001486_abnormal_startle_reflex | 1.70531096 |
| 35 | MP0002736_abnormal_nociception_after | 1.57854337 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.51308166 |
| 37 | MP0008875_abnormal_xenobiotic_pharmacok | 1.51016501 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.50184592 |
| 39 | MP0005379_endocrine/exocrine_gland_phen | 1.46658881 |
| 40 | MP0000372_irregular_coat_pigmentation | 1.44141463 |
| 41 | MP0000015_abnormal_ear_pigmentation | 1.43856670 |
| 42 | MP0003635_abnormal_synaptic_transmissio | 1.40935277 |
| 43 | MP0001485_abnormal_pinna_reflex | 1.39763341 |
| 44 | MP0002064_seizures | 1.37470853 |
| 45 | MP0005310_abnormal_salivary_gland | 1.32658195 |
| 46 | MP0001970_abnormal_pain_threshold | 1.28069507 |
| 47 | MP0003011_delayed_dark_adaptation | 1.26727645 |
| 48 | MP0002572_abnormal_emotion/affect_behav | 1.26420882 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.25879201 |
| 50 | MP0002734_abnormal_mechanical_nocicepti | 1.17918276 |
| 51 | MP0002693_abnormal_pancreas_physiology | 1.17138687 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.13417754 |
| 53 | MP0002234_abnormal_pharynx_morphology | 1.10529451 |
| 54 | MP0001790_abnormal_immune_system | 1.08305005 |
| 55 | MP0005387_immune_system_phenotype | 1.08305005 |
| 56 | MP0002557_abnormal_social/conspecific_i | 1.05808580 |
| 57 | MP0001919_abnormal_reproductive_system | 1.04618462 |
| 58 | MP0000631_abnormal_neuroendocrine_gland | 1.02122843 |
| 59 | MP0001348_abnormal_lacrimal_gland | 1.01127009 |
| 60 | MP0005671_abnormal_response_to | 0.99532660 |
| 61 | MP0001529_abnormal_vocalization | 0.97918049 |
| 62 | MP0002095_abnormal_skin_pigmentation | 0.97543546 |
| 63 | MP0001905_abnormal_dopamine_level | 0.97276572 |
| 64 | MP0005389_reproductive_system_phenotype | 0.96939782 |
| 65 | MP0005410_abnormal_fertilization | 0.96425761 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 0.96300764 |
| 67 | MP0004043_abnormal_pH_regulation | 0.96141993 |
| 68 | MP0004381_abnormal_hair_follicle | 0.95239852 |
| 69 | MP0001986_abnormal_taste_sensitivity | 0.93660637 |
| 70 | MP0003890_abnormal_embryonic-extraembry | 0.92161375 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 0.91782690 |
| 72 | MP0001440_abnormal_grooming_behavior | 0.91137766 |
| 73 | MP0006276_abnormal_autonomic_nervous | 0.87339385 |
| 74 | MP0002063_abnormal_learning/memory/cond | 0.86936928 |
| 75 | MP0003252_abnormal_bile_duct | 0.85588223 |
| 76 | MP0001873_stomach_inflammation | 0.85533493 |
| 77 | MP0006072_abnormal_retinal_apoptosis | 0.85325790 |
| 78 | MP0002168_other_aberrant_phenotype | 0.83953542 |
| 79 | MP0001664_abnormal_digestion | 0.83829729 |
| 80 | MP0006035_abnormal_mitochondrial_morpho | 0.83778109 |
| 81 | MP0005253_abnormal_eye_physiology | 0.83269350 |
| 82 | MP0010386_abnormal_urinary_bladder | 0.82834610 |
| 83 | MP0002229_neurodegeneration | 0.82452755 |
| 84 | MP0002751_abnormal_autonomic_nervous | 0.82432873 |
| 85 | MP0004885_abnormal_endolymph | 0.81913593 |
| 86 | MP0004924_abnormal_behavior | 0.80804754 |
| 87 | MP0005386_behavior/neurological_phenoty | 0.80804754 |
| 88 | MP0002938_white_spotting | 0.78647392 |
| 89 | MP0000013_abnormal_adipose_tissue | 0.78375226 |
| 90 | MP0004484_altered_response_of | 0.77677048 |
| 91 | MP0003633_abnormal_nervous_system | 0.77281462 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.77121344 |
| 93 | MP0002184_abnormal_innervation | 0.76391930 |
| 94 | MP0002822_catalepsy | 0.74887218 |
| 95 | MP0005085_abnormal_gallbladder_physiolo | 0.74716604 |
| 96 | MP0005195_abnormal_posterior_eye | 0.73482259 |
| 97 | MP0000778_abnormal_nervous_system | 0.72769142 |
| 98 | MP0005174_abnormal_tail_pigmentation | 0.71299818 |
| 99 | MP0010329_abnormal_lipoprotein_level | 0.69323625 |
| 100 | MP0005332_abnormal_amino_acid | 0.68389731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Renal cortical cysts (HP:0000803) | 3.94653267 |
| 2 | Thyroid-stimulating hormone excess (HP:0002925) | 3.69010543 |
| 3 | Abnormality of the renal cortex (HP:0011035) | 3.68308154 |
| 4 | Gaze-evoked nystagmus (HP:0000640) | 3.61737399 |
| 5 | Depressed nasal tip (HP:0000437) | 3.61571861 |
| 6 | Intestinal atresia (HP:0011100) | 3.57165076 |
| 7 | Type II lissencephaly (HP:0007260) | 3.45896514 |
| 8 | Pancreatic cysts (HP:0001737) | 3.36392024 |
| 9 | Tubular atrophy (HP:0000092) | 3.35973381 |
| 10 | Pancreatic fibrosis (HP:0100732) | 3.19124349 |
| 11 | Medial flaring of the eyebrow (HP:0010747) | 3.11519576 |
| 12 | Volvulus (HP:0002580) | 3.01768977 |
| 13 | Focal motor seizures (HP:0011153) | 2.96995609 |
| 14 | Increased corneal curvature (HP:0100692) | 2.92634824 |
| 15 | Keratoconus (HP:0000563) | 2.92634824 |
| 16 | Broad alveolar ridges (HP:0000187) | 2.81295153 |
| 17 | Sclerocornea (HP:0000647) | 2.81201949 |
| 18 | Lissencephaly (HP:0001339) | 2.77416519 |
| 19 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.76960380 |
| 20 | Congenital stationary night blindness (HP:0007642) | 2.72112934 |
| 21 | Renal Fanconi syndrome (HP:0001994) | 2.71194032 |
| 22 | Exercise-induced myalgia (HP:0003738) | 2.70783494 |
| 23 | Calf muscle hypertrophy (HP:0008981) | 2.70065668 |
| 24 | Chronic diarrhea (HP:0002028) | 2.69988939 |
| 25 | Acute necrotizing encephalopathy (HP:0006965) | 2.66045175 |
| 26 | Focal seizures (HP:0007359) | 2.62266707 |
| 27 | Progressive inability to walk (HP:0002505) | 2.61470929 |
| 28 | Inability to walk (HP:0002540) | 2.60003870 |
| 29 | Neonatal hypoglycemia (HP:0001998) | 2.59915939 |
| 30 | Molar tooth sign on MRI (HP:0002419) | 2.57786655 |
| 31 | Abnormality of midbrain morphology (HP:0002418) | 2.57786655 |
| 32 | Chorioretinal atrophy (HP:0000533) | 2.56341196 |
| 33 | Pendular nystagmus (HP:0012043) | 2.52468928 |
| 34 | Cerebellar dysplasia (HP:0007033) | 2.50161707 |
| 35 | Acute encephalopathy (HP:0006846) | 2.49918588 |
| 36 | Type 2 muscle fiber atrophy (HP:0003554) | 2.42611702 |
| 37 | Genetic anticipation (HP:0003743) | 2.41730623 |
| 38 | Progressive macrocephaly (HP:0004481) | 2.41348960 |
| 39 | Attenuation of retinal blood vessels (HP:0007843) | 2.40715274 |
| 40 | Nephronophthisis (HP:0000090) | 2.39518082 |
| 41 | 3-Methylglutaconic aciduria (HP:0003535) | 2.39088717 |
| 42 | Toxemia of pregnancy (HP:0100603) | 2.35713979 |
| 43 | Hypoproteinemia (HP:0003075) | 2.34548240 |
| 44 | Median cleft lip (HP:0000161) | 2.34085552 |
| 45 | Mitochondrial inheritance (HP:0001427) | 2.34075015 |
| 46 | Abnormality of the labia minora (HP:0012880) | 2.33424439 |
| 47 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.30433853 |
| 48 | Increased hepatocellular lipid droplets (HP:0006565) | 2.29798762 |
| 49 | Gastrointestinal atresia (HP:0002589) | 2.25674931 |
| 50 | Methylmalonic acidemia (HP:0002912) | 2.25195107 |
| 51 | Mesangial abnormality (HP:0001966) | 2.23747206 |
| 52 | Anhidrosis (HP:0000970) | 2.23356691 |
| 53 | Increased CSF lactate (HP:0002490) | 2.22887725 |
| 54 | Lipid accumulation in hepatocytes (HP:0006561) | 2.20572635 |
| 55 | Abolished electroretinogram (ERG) (HP:0000550) | 2.19667625 |
| 56 | True hermaphroditism (HP:0010459) | 2.19538415 |
| 57 | Progressive cerebellar ataxia (HP:0002073) | 2.15313384 |
| 58 | Pachygyria (HP:0001302) | 2.14458166 |
| 59 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.12204356 |
| 60 | Abnormality of the renal medulla (HP:0100957) | 2.11547835 |
| 61 | Prolonged QT interval (HP:0001657) | 2.06986727 |
| 62 | Optic nerve hypoplasia (HP:0000609) | 2.06511256 |
| 63 | Disproportionate short-trunk short stature (HP:0003521) | 1.98931058 |
| 64 | Abnormality of renal resorption (HP:0011038) | 1.97587139 |
| 65 | Palpebral edema (HP:0100540) | 1.93492761 |
| 66 | Gait imbalance (HP:0002141) | 1.93203078 |
| 67 | Muscle stiffness (HP:0003552) | 1.92560284 |
| 68 | Lip pit (HP:0100267) | 1.92516736 |
| 69 | Abnormal drinking behavior (HP:0030082) | 1.92458473 |
| 70 | Polydipsia (HP:0001959) | 1.92458473 |
| 71 | Optic disc pallor (HP:0000543) | 1.91759182 |
| 72 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.91586587 |
| 73 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.91586587 |
| 74 | Poor suck (HP:0002033) | 1.91081711 |
| 75 | Retinal dysplasia (HP:0007973) | 1.90936726 |
| 76 | Limb dystonia (HP:0002451) | 1.90677387 |
| 77 | Abnormal albumin level (HP:0012116) | 1.86217371 |
| 78 | Hypoalbuminemia (HP:0003073) | 1.86217371 |
| 79 | Megalencephaly (HP:0001355) | 1.86138957 |
| 80 | Thyroiditis (HP:0100646) | 1.82001755 |
| 81 | Agitation (HP:0000713) | 1.81558914 |
| 82 | Decreased circulating renin level (HP:0003351) | 1.81136916 |
| 83 | Congenital primary aphakia (HP:0007707) | 1.80862553 |
| 84 | Ketoacidosis (HP:0001993) | 1.80838461 |
| 85 | Amblyopia (HP:0000646) | 1.79452821 |
| 86 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.79398935 |
| 87 | Neonatal respiratory distress (HP:0002643) | 1.78608376 |
| 88 | Limb hypertonia (HP:0002509) | 1.78176656 |
| 89 | Poor head control (HP:0002421) | 1.77165291 |
| 90 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.77087623 |
| 91 | Abnormality of urine glucose concentration (HP:0011016) | 1.76727586 |
| 92 | Glycosuria (HP:0003076) | 1.76727586 |
| 93 | Muscle fiber atrophy (HP:0100295) | 1.75163135 |
| 94 | Large for gestational age (HP:0001520) | 1.73490564 |
| 95 | Hypoplasia of the thymus (HP:0000778) | 1.73007710 |
| 96 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.72775144 |
| 97 | Subaortic stenosis (HP:0001682) | 1.72775144 |
| 98 | Cystic liver disease (HP:0006706) | 1.72706435 |
| 99 | Exertional dyspnea (HP:0002875) | 1.72416959 |
| 100 | Nephrogenic diabetes insipidus (HP:0009806) | 1.72120876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.36706915 |
| 2 | ADRBK2 | 4.16548599 |
| 3 | MAP4K2 | 3.46532403 |
| 4 | ACVR1B | 3.07974325 |
| 5 | PHKG2 | 2.82789330 |
| 6 | PHKG1 | 2.82789330 |
| 7 | NUAK1 | 2.79889095 |
| 8 | TESK1 | 2.57664362 |
| 9 | MAPKAPK3 | 2.39044430 |
| 10 | STK16 | 1.95669592 |
| 11 | GRK1 | 1.85861399 |
| 12 | PAK3 | 1.84490640 |
| 13 | MAPKAPK5 | 1.66771840 |
| 14 | EPHA4 | 1.65398733 |
| 15 | MUSK | 1.61379935 |
| 16 | BMPR1B | 1.55997758 |
| 17 | TXK | 1.44421276 |
| 18 | PAK6 | 1.44116630 |
| 19 | TNK2 | 1.43888521 |
| 20 | CSNK1G2 | 1.42534338 |
| 21 | PINK1 | 1.39956026 |
| 22 | MAPK13 | 1.27879546 |
| 23 | TYRO3 | 1.19915932 |
| 24 | CSNK1G3 | 1.19503451 |
| 25 | OXSR1 | 1.18648693 |
| 26 | MARK1 | 1.18610731 |
| 27 | PRKCG | 1.15097551 |
| 28 | FES | 1.14910311 |
| 29 | CSNK1G1 | 1.10626100 |
| 30 | TAOK3 | 1.10625386 |
| 31 | WNK4 | 1.09858931 |
| 32 | ZAK | 1.09529911 |
| 33 | EIF2AK3 | 1.09170690 |
| 34 | KSR1 | 1.08794016 |
| 35 | CASK | 1.06875916 |
| 36 | CLK1 | 1.05823556 |
| 37 | ADRBK1 | 1.01523968 |
| 38 | MAP3K4 | 0.96983850 |
| 39 | STK39 | 0.96792228 |
| 40 | DAPK2 | 0.96138866 |
| 41 | PRKCE | 0.95552010 |
| 42 | EPHB2 | 0.95176340 |
| 43 | STK3 | 0.95049511 |
| 44 | CCNB1 | 0.93192161 |
| 45 | TSSK6 | 0.92662201 |
| 46 | NEK1 | 0.91773087 |
| 47 | WNK3 | 0.91067506 |
| 48 | MAP3K12 | 0.90828008 |
| 49 | MAP2K7 | 0.88876396 |
| 50 | PRKAA2 | 0.87483562 |
| 51 | VRK1 | 0.86077588 |
| 52 | NTRK2 | 0.85754475 |
| 53 | PIK3CA | 0.82870128 |
| 54 | ERBB2 | 0.82368028 |
| 55 | DAPK1 | 0.80611533 |
| 56 | FGFR2 | 0.79880481 |
| 57 | INSRR | 0.79845878 |
| 58 | NTRK1 | 0.76415793 |
| 59 | MARK3 | 0.74242128 |
| 60 | FER | 0.71816467 |
| 61 | ITK | 0.71714556 |
| 62 | TNIK | 0.71213882 |
| 63 | STK24 | 0.70544718 |
| 64 | MST4 | 0.69858493 |
| 65 | MAP3K11 | 0.69728904 |
| 66 | VRK2 | 0.67518233 |
| 67 | IRAK1 | 0.65279105 |
| 68 | TAF1 | 0.64975862 |
| 69 | MKNK2 | 0.62222106 |
| 70 | PIK3CG | 0.59687481 |
| 71 | DYRK2 | 0.59189958 |
| 72 | TAOK1 | 0.58488138 |
| 73 | STK38 | 0.57275090 |
| 74 | BUB1 | 0.56995871 |
| 75 | CAMK2A | 0.56573564 |
| 76 | PLK2 | 0.54930657 |
| 77 | ERBB3 | 0.53169279 |
| 78 | NLK | 0.52663679 |
| 79 | MINK1 | 0.51545078 |
| 80 | EIF2AK2 | 0.51042922 |
| 81 | CSNK1D | 0.50951295 |
| 82 | PLK3 | 0.50448045 |
| 83 | CSNK1A1L | 0.48779019 |
| 84 | LATS1 | 0.48765311 |
| 85 | TAOK2 | 0.47737895 |
| 86 | CSNK1A1 | 0.44434973 |
| 87 | IKBKB | 0.42425251 |
| 88 | PRKACA | 0.42305905 |
| 89 | TLK1 | 0.42075142 |
| 90 | TGFBR1 | 0.41129670 |
| 91 | CDK8 | 0.41036598 |
| 92 | MAP2K1 | 0.37816622 |
| 93 | STK38L | 0.37177004 |
| 94 | RPS6KA4 | 0.37063947 |
| 95 | PRKCQ | 0.36584063 |
| 96 | STK11 | 0.36271824 |
| 97 | TEC | 0.35721659 |
| 98 | PRKCB | 0.32867735 |
| 99 | RAF1 | 0.32866199 |
| 100 | MAP2K6 | 0.30276241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.72940295 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.35659857 |
| 3 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.34231670 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.29821124 |
| 5 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.28857114 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.23268264 |
| 7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.20347718 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.18891827 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.11369083 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11059207 |
| 11 | Nicotine addiction_Homo sapiens_hsa05033 | 2.04518562 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.01755271 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.96320450 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 1.93003327 |
| 15 | RNA polymerase_Homo sapiens_hsa03020 | 1.84618949 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.81728653 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.77713901 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.73128624 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.61963559 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.58131441 |
| 21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.56800033 |
| 22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.52985999 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.44379056 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.43912157 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.37797406 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.35502441 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.32214818 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.30428153 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.28628190 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.28368086 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.28031064 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.27131751 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25493706 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24339719 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.23814466 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.23443804 |
| 37 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.20100136 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14637320 |
| 39 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12149685 |
| 40 | Olfactory transduction_Homo sapiens_hsa04740 | 1.11817784 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.11365573 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.08748722 |
| 43 | Circadian entrainment_Homo sapiens_hsa04713 | 1.08169558 |
| 44 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.06484952 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.05208931 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04062514 |
| 47 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.03801291 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.03672679 |
| 49 | Huntingtons disease_Homo sapiens_hsa05016 | 1.03217716 |
| 50 | Insulin secretion_Homo sapiens_hsa04911 | 1.02725793 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00365497 |
| 52 | Homologous recombination_Homo sapiens_hsa03440 | 0.99866282 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.97605755 |
| 54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95346016 |
| 55 | Allograft rejection_Homo sapiens_hsa05330 | 0.91827045 |
| 56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.91428166 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90351841 |
| 58 | GABAergic synapse_Homo sapiens_hsa04727 | 0.89887557 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89155943 |
| 60 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.89064886 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.88989538 |
| 62 | Salivary secretion_Homo sapiens_hsa04970 | 0.88144769 |
| 63 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.87834438 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87245350 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.82454314 |
| 66 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.80234988 |
| 67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78362085 |
| 68 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78084579 |
| 69 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76046278 |
| 70 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.75971624 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.74594635 |
| 72 | Purine metabolism_Homo sapiens_hsa00230 | 0.74178279 |
| 73 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.73527695 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.70443640 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67644876 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61664220 |
| 77 | Long-term depression_Homo sapiens_hsa04730 | 0.60059604 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59933926 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59438378 |
| 80 | RNA transport_Homo sapiens_hsa03013 | 0.57033498 |
| 81 | RNA degradation_Homo sapiens_hsa03018 | 0.56177204 |
| 82 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.56003936 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.55588868 |
| 84 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.55280010 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53617395 |
| 86 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52967650 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51345053 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50681382 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.50613235 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49520258 |
| 91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49498216 |
| 92 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49386523 |
| 93 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.46403426 |
| 94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44936014 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42001441 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41553294 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.41410638 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.40864503 |
| 99 | Cocaine addiction_Homo sapiens_hsa05030 | 0.39363080 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39191138 |

